Cited by 56Wnt/β-catenin signaling in development and cancerAlzheimer's disease research and treatmentsBioinformatics and Genomic Networks

Genome-Wide Analysis of a Wnt1-Regulated Transcriptional Network Implicates Neurodegenerative Pathways

Open access
Wexler, Eric M., Rosen, Ezra, Lu, Daning, Osborn, Gregory E., Martin, Elizabeth, Raybould, Helen, Geschwind, Daniel H.·2011·Science Signaling

Abstract

A systems biology approach identifies connections between Wnt1 signaling and neurodegenerative diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scisignal.2002282

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Variation affecting synaptic maintenance, glial support, and cellular resilience may modify disease risk and progression.

    “suggesting that variation affecting synaptic maintenance, glial support, and cellular resilience may modify disease risk and progression [98].”

    From Genetic drivers of progression in Alzheimer’s disease are distinct from disease risk (2026) · cites this paper as [98]

    The Introduction links GRN haploinsufficiency to inherited frontotemporal dementia, and the Discussion (Regulation of PGRN expression; page unavailable) proposes that Wnt-related changes could affect neuronal survival and the course of disease. That supports the claim’s hedged point about cellular resilience, but our copy does not establish that variation affecting synaptic maintenance or glial support modifies disease risk or progression. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Pathways involving Wnt signalling and developmental transcriptional regulation, relevant to genes such as ZNRF3 and MN1, have been implicated in GWAS-based pathway enrichment analyses of neurodegenerative disease.

    “pathways involving Wnt signalling and developmental transcriptional regulation, relevant to genes such as ZNRF3 and MN1, have been implicated in GWAS-based pathway enrichment analyses of neurodegenerative disease”

    From Genetic drivers of progression in Alzheimer’s disease are distinct from disease risk (2026) · cites this paper as [98]

    The Results (Pathway analysis; page unavailable) report enrichment of Wnt-regulated genes in neurodegenerative-disease pathways. But the analysis used gene-expression data from Wnt1-treated cells, not a GWAS-based pathway enrichment analysis; the cited passages also do not establish a connection to ZNRF3 or MN1. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • Edge relationships using mutual information or other association measures might be necessary to accurately detect modules in time-series data, which can be non-monotonic.

    “edge relationships using mutual information or other association measures might be necessary to accurately detect modules in time-series data, which can be non-monotonic46–48.”
  • Experimental validation of predictions from these networks showed that cross-species approaches can identify consistent, high-confidence perturbations in neurodegenerative disease.

    “Experimental validation of predictions from these networks showed that this cross-species approach can identify consistent, high-confidence perturbations in neurodegenerative disease46,153.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 140 · Cited by 56

Research works printed but not linked: 3

  1. [48]MacKay DJC Information Theory, Inference, and Learning Algorithms 2003 Cambridge Univ. Press Cambridge, UK/New York
  2. [69]Lèbre S Stochastic Process Analysis for Genomics and Dynamic Bayesian Networks Inference PhD thesis 2007 Université d’Evry-Val-d’Essonne Evry, France
  3. [84]Papassotiropoulos A Wollmer MA Tsolaki M Brunner F Molyva D Lütjohann D Nitsch RM Hock C A cluster of cholesterol-related genes confers susceptibility for Alzheimer’s disease J. Clin. Psychiatry 2005 66 940 947 16013913

Authors
Wexler, E. M., Rosen, E., Lu, D., Osborn, G. E., Martin, E., Raybould, H., & Geschwind, D. H.
Affiliations
  • University of California, Los Angeles (US)
  • University of California, Davis (US)
Corresponding author
Wexler, Eric M.
Venue
Science Signaling
Published
2011-10-04
Volume
4
Issue
193
Pages
ra65-ra65
ISSN
  • 1937-9145 (ISSN-L)
  • 1945-0877
OpenAlex
W2043326045
Cited by
56
References
140
Citations by year
2026: 1 · 2025: 1 · 2024: 4 · 2023: 1 · 2022: 5 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 5 · 2015: 7 · 2014: 6 · 2013: 7 · 2012: 9
FWCI
2.86
Type
journal article
Language
en
Open access
Locations
  • Science Signaling (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute on Aging (R01AG026938)
  • National Institute of Mental Health (K08 MH74362, R01MH060233, K08MH074362, R37MH060233)
  • National Institute of Neurological Disorders and Stroke (T32NS048004)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
Keywords
Wnt1, Wnt signaling, non-canonical Wnt pathway, canonical Wnt pathway, transcriptional regulatory networks, gene expression oscillations, human neural progenitor cells, presenilin 1, granulin, Alzheimer's disease, frontotemporal dementia, neurodegeneration, cell death, reciprocal gene regulation
MeSH terms
Progranulins, Alzheimer Disease, Cells, Cultured, Gene Expression Regulation, Humans, Nerve Tissue Proteins, Transcription, Genetic, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Intercellular Signaling Peptides and Proteins, Wnt1 Protein, Presenilin-1, Genome-Wide Association Study, Frontotemporal Dementia, Wnt Signaling Pathway

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review